MacroGenics Inc. (NASDAQ:MGNX) went up by 8.69% from its latest closing price compared to the recent 1-year high of $32.81. The company’s stock price has collected -40.26% of loss in the last five trading sessions.
Is It Worth Investing in MacroGenics Inc. (NASDAQ :MGNX) Right Now?
Plus, the 36-month beta value for MGNX is at 2.12. Opinions of the stock are interesting as 10 analysts out of 12 who provided ratings for MacroGenics Inc. declared the stock was a “buy,” while 1 rated the stock as “overweight,” 1 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $27.50, which is $23.7 above the current price. MGNX currently public float of 58.11M and currently shorts hold a 8.46% ratio of that float. Today, the average trading volume of MGNX was 743.14K shares.
MGNX’s Market Performance
MGNX stocks went down by -40.26% for the week, with a monthly drop of -48.44% and a quarterly performance of -59.74%, while its annual performance rate touched -84.84%. The volatility ratio for the week stands at 15.82% while the volatility levels for the past 30 days are set at 8.89% for MacroGenics Inc.. The simple moving average for the period of the last 20 days is -37.20% for MGNX stocks with a simple moving average of -71.19% for the last 200 days.
Analysts’ Opinion of MGNX
Citigroup, on the other hand, stated in their research note that they expect to see MGNX reach a price target of $21, previously predicting the price at $23. The rating they have provided for MGNX stocks is “Buy” according to the report published on February 28th, 2022.
BMO Capital Markets gave a rating of “Outperform” to MGNX, setting the target price at $31 in the report published on February 11th of the current year.
MGNX Trading at -44.30% from the 50-Day Moving Average
After a stumble in the market that brought MGNX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -85.89% of loss for the given period.
Volatility was left at 8.89%, however, over the last 30 days, the volatility rate increased by 15.82%, as shares sank -44.01% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -50.48% lower at present.
During the last 5 trading sessions, MGNX fell by -40.26%, which changed the moving average for the period of 200-days by -81.79% in comparison to the 20-day moving average, which settled at $7.19. In addition, MacroGenics Inc. saw -71.15% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at MGNX starting from BIOTECH TARGET N V, who purchase 200,000 shares at the price of $18.50 back on Nov 19. After this action, BIOTECH TARGET N V now owns 7,275,564 shares of MacroGenics Inc., valued at $3,700,320 using the latest closing price.
BIOTECH TARGET N V, the 10% Owner of MacroGenics Inc., purchase 100,000 shares at $20.47 during a trade that took place back on Sep 29, which means that BIOTECH TARGET N V is holding 7,075,564 shares at $2,047,460 based on the most recent closing price.
Stock Fundamentals for MGNX
Current profitability levels for the company are sitting at:
- -261.85 for the present operating margin
- +82.04 for the gross margin
The net margin for MacroGenics Inc. stands at -260.97. Equity return is now at value -84.50, with -61.00 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 3.75.